XML 37 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Shareholders' Equity (Tables)
6 Months Ended
Jul. 29, 2017
Stockholders' Equity Note [Abstract]  
Schedule of Changes in Shareholders' Equity and Noncontrolling Interests
 
The following tables set forth the changes in Caleres, Inc. shareholders’ equity and noncontrolling interests for the twenty-six weeks ended July 29, 2017 and July 30, 2016:

($ thousands)
Caleres, Inc. Shareholders’ Equity

Noncontrolling Interests

Total Equity

Equity at January 28, 2017
$
613,117

$
1,369

$
614,486

Net earnings
32,497

61

32,558

Other comprehensive income
2,383

15

2,398

Dividends paid
(6,030
)

(6,030
)
Acquisition of treasury stock
(5,993
)

(5,993
)
Issuance of common stock under share-based plans, net
(2,490
)

(2,490
)
Cumulative-effect adjustment from adoption of ASU 2016-09
441


441

Share-based compensation expense
5,804


5,804

Equity at July 29, 2017
$
639,729

$
1,445

$
641,174

 
($ thousands)
Caleres, Inc. Shareholders’ Equity

Noncontrolling Interests

Total Equity

Equity at January 30, 2016
$
601,484

$
988

$
602,472

Net earnings
37,551

6

37,557

Other comprehensive income (loss)
489

(16
)
473

Dividends paid
(6,089
)

(6,089
)
Acquisition of treasury stock
(23,139
)

(23,139
)
Issuance of common stock under share-based plans, net
(4,086
)

(4,086
)
Excess tax benefit related to share-based plans
3,248


3,248

Share-based compensation expense
4,329


4,329

Equity at July 30, 2016
$
613,787

$
978

$
614,765

Schedule of Accumulated Other Comprehensive Loss
The following table sets forth the changes in accumulated other comprehensive loss (OCL) by component for the periods ended July 29, 2017 and July 30, 2016:
($ thousands)
Foreign Currency Translation

Pension and Other Postretirement Transactions (1)

Derivative Financial Instrument Transactions (2)

Accumulated Other Comprehensive (Loss) Income

Balance April 29, 2017
$
(348
)
$
(29,666
)
$
236

$
(29,778
)
Other comprehensive income (loss) before reclassifications
1,820


(295
)
1,525

Reclassifications:
 
 
 


Amounts reclassified from accumulated other comprehensive loss

500

(164
)
336

Tax (benefit) provision

(191
)
57

(134
)
Net reclassifications

309

(107
)
202

Other comprehensive income (loss)
1,820

309

(402
)
1,727

Balance July 29, 2017
$
1,472

$
(29,357
)
$
(166
)
$
(28,051
)
 
 
 
 
 
Balance April 30, 2016
$
1,410

$
(5,644
)
$
180

$
(4,054
)
Other comprehensive loss before reclassifications
(804
)

(351
)
(1,155
)
Reclassifications:
 
 
 
 
Amounts reclassified from accumulated other comprehensive loss

(477
)
190

(287
)
Tax provision (benefit)

189

(68
)
121

Net reclassifications

(288
)
122

(166
)
Other comprehensive loss
(804
)
(288
)
(229
)
(1,321
)
Balance July 30, 2016
$
606

$
(5,932
)
$
(49
)
$
(5,375
)
 
 
 
 
 
Balance January 28, 2017
$
192

$
(30,084
)
$
(542
)
(30,434
)
Other comprehensive income before reclassifications
1,280


458

1,738

Reclassifications:
 
 
 


Amounts reclassified from accumulated other comprehensive loss

1,179

(117
)
1,062

Tax (benefit) provision

(452
)
35

(417
)
Net reclassifications

727

(82
)
645

Other comprehensive income
1,280

727

376

2,383

Balance July 29, 2017
$
1,472

$
(29,357
)
$
(166
)
$
(28,051
)
 
 
 
 


Balance January 30, 2016
$
(900
)
$
(5,356
)
$
392

$
(5,864
)
Other comprehensive income (loss) before reclassifications
1,506


(639
)
867

Reclassifications:
 
 
 


Amounts reclassified from accumulated other comprehensive loss

(954
)
313

(641
)
Tax provision (benefit)

378

(115
)
263

Net reclassifications

(576
)
198

(378
)
Other comprehensive income (loss)
1,506

(576
)
(441
)
489

Balance July 30, 2016
$
606

$
(5,932
)
$
(49
)
$
(5,375
)

(1)
Amounts reclassified are included in selling and administrative expenses. See Note 11 to the condensed consolidated financial statements for additional information related to pension and other postretirement benefits.
(2)
Amounts reclassified are included in net sales, costs of goods sold, selling and administrative expenses and interest expense. See Notes 12 and 13 to the condensed consolidated financial statements for additional information related to derivative financial instruments.